Compare BJ & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJ | CRL |
|---|---|---|
| Founded | 1984 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 10.8B |
| IPO Year | 2018 | 1999 |
| Metric | BJ | CRL |
|---|---|---|
| Price | $97.84 | $233.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 12 |
| Target Price | $108.36 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 1.6M | 796.7K |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.50 | N/A |
| EPS | ★ 1.10 | N/A |
| Revenue | ★ $21,457,274,000.00 | $1,857,601,000.00 |
| Revenue This Year | $8.86 | N/A |
| Revenue Next Year | $6.50 | $3.04 |
| P/E Ratio | $86.11 | ★ N/A |
| Revenue Growth | 4.66 | ★ 10.48 |
| 52 Week Low | $83.21 | $144.26 |
| 52 Week High | $110.92 | $238.85 |
| Indicator | BJ | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 68.48 | 64.71 |
| Support Level | $89.11 | $215.89 |
| Resistance Level | $100.31 | N/A |
| Average True Range (ATR) | 2.53 | 8.28 |
| MACD | 0.74 | -1.51 |
| Stochastic Oscillator | 95.38 | 71.38 |
BJ's Wholesale Club, founded in 1984, operates a membership-based warehouse club model primarily along the US East Coast, with roughly 250 clubs and a growing domestic presence across 21 states. In fiscal 2024, the company generated over $20 billion in revenue. BJ's offers a value-oriented assortment skewed toward grocery, perishables, and consumables (71% of sales), general merchandise (11%), and gasoline (18%). Its business model is supported by recurring membership fee income and private-label brands such as Wellsley Farms and Berkley Jensen.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.